Finnrick - Ensuring a Safer and More Transparent Supply Chain
Quenna PMQ

Quenna PMQ

Tirzepatide

Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from Quenna PMQ between 16 Jul 2025 and 1 Oct 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).

Finnrick Rating™
Tentative Rating
Quenna PMQ
Tirzepatide
Tested 3 Samples
Last test 1 Oct 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Quenna PMQ

Samples are tested in commercial labs

Tests Count

3

Scores

AVG6.7MIN4.9MAX8.0

Last

1 Oct 2025

First

16 Jul 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
1 Oct 2025View4.920mg23.800mg+19.0%99.80%(no batch ID)(no data)Lab GPublic
5 Aug 2025View7.230mg31.140mg+3.8%99.56%(no batch ID)(no data)Lab DPublic
16 Jul 2025View8.040mg39.400mg-1.5%99.97%(no batch ID)White Label / Silver Crimp / Green CapLab EPublic